On May 29, 2025, Barclays downgraded Aspen Aerogels, Inc. (NYSE:ASPN) from Overweight to Equal Weight. The lead analyst, David Anderson, also stated that the new price target has been revised ...
Craig-Hallum lowered the firm’s price target on Aspen Aerogels (ASPN) to $30 from $38 and keeps a Buy rating on the shares following Q3 results and FY24 guidance. The firm told investors that this was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results